Therefore, induction of HO-1 contributes to cytoprotection and anti-inflammation [25]–[27], and HO-1 may be a therapeutic target in neurodegenerative diseases and brain inflammation [28]–[30]. This evidence concerns the gene HMOX1 and neurodegenerative disease.